The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study
Using a microsimulation model, Oliver Mytton and colleagues estimate the health benefits of the NHS Health Check programme in the UK and its potential impact on reducing health inequalities.
Vyšlo v časopise:
The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study. PLoS Med 15(3): e32767. doi:10.1371/journal.pmed.1002517
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002517
Souhrn
Using a microsimulation model, Oliver Mytton and colleagues estimate the health benefits of the NHS Health Check programme in the UK and its potential impact on reducing health inequalities.
Zdroje
1. Frieden TR, Berwick DM. The “Million Hearts” initiative—preventing heart attacks and strokes. N Engl J Med. 2011;365: e27. doi: 10.1056/NEJMp1110421 21913835
2. Murray CJL, Richards MA, Newton JN, Fenton KA, Anderson HR, Atkinson C, et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet. 2013;381: 997–1020. doi: 10.1016/S0140-6736(13)60355-4 23668584
3. Public Health England. From evidence into action: opportunities to protect and improve the nation’s health [Internet]. London; 2014. Available: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/366852/PHE_Priorities.pdf
4. The World Health Organisation. Global action plan to prevent and control non-communicable diseases [Internet]. Geneva; 2013. Available: http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf
5. British Heart Foundation. CVD Statistics—BHF UK Factsheet. London; 2016.
6. Kotseva K, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V, et al. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol. 2016;23: 2007–2018. doi: 10.1177/2047487316667784 27638542
7. Department of Health. Putting Prevention First—Vascular Checks: risk assessment and management [Internet]. 2008. Available: www.healthcheck.nhs.uk/document.php?o = 227
8. Public Health England. NHS Health Check Best Practice Guidance [Internet]. London; 2017. Available: http://www.healthcheck.nhs.uk/commissioners_and_providers/guidance/national_guidance1/
9. Capewell S, McCartney M, Holland W. NHS Health Checks—a naked emperor? J Public Health (Oxf). 2015;37: 187–92. doi: 10.1093/pubmed/fdv063 26022810
10. Krogsbøll LT, Jørgensen KJ, Grønhøj Larsen C, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis. BMJ. British Medical Journal Publishing Group; 2012;345: e7191. doi: 10.1136/bmj.e7191 23169868
11. Jørgensen T, Jacobsen RK, Toft U, Aadahl M, Glümer C, Pisinger C. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ. British Medical Journal Publishing Group; 2014;348: g3617. doi: 10.1136/bmj.g3617 24912589
12. Waterall J, Greaves F, Kearney M, Fenton KA. Invited debate: NHS Health Check: an innovative component of local adult health improvement and well-being programmes in England. J Public Health (Bangkok). Oxford University Press; 2015;37: 177–184. doi: 10.1093/pubmed/fdv062 26022808
13. Robson J, Dostal I, Sheikh A, Eldridge S, Madurasinghe V, Griffiths C, et al. The NHS Health Check in England: an evaluation of the first 4 years. BMJ Open. British Medical Journal Publishing Group; 2016;6: e008840. doi: 10.1136/bmjopen-2015-008840 26762161
14. Chang KC-M, Soljak M, Lee JT, Woringer M, Johnston D, Khunti K, et al. Coverage of a national cardiovascular risk assessment and management programme (NHS Health Check): Retrospective database study. Prev Med (Baltim). 2015;78: 1–8. doi: 10.1016/j.ypmed.2015.05.022 26051202
15. Kypridemos C, Allen K, Hickey GL, Guzman-Castillo M, Bandosz P, Buchan I, et al. Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options. BMJ. 2016;353.
16. Schuetz CA, Alperin P, Guda S, van Herick A, Cariou B, Eddy D, et al. A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis. Federici M, editor. PLoS One. Public Library of Science; 2013;8: e66454. doi: 10.1371/journal.pone.0066454 23869204
17. Local Government Association, Public Health England. NHS Health Check—Frequently Asked Questions [Internet]. London; 2013. Available: www.healthcheck.nhs.uk/document.php?o=448
18. The BBC. In full: Brown speech on the NHS. In: BBC News [Internet]. 2008 [cited 1 Mar 2017]. Available: http://news.bbc.co.uk/1/hi/uk_politics/7175083.stm
19. The BBC. Free health checks could save lives, Jeremy Hunt says. In: BBC News [Internet]. 2013 [cited 1 Mar 2017]. Available: http://www.bbc.co.uk/news/health-23394314
20. Krska J, du Plessis R, Chellaswamy H. Views and experiences of the NHS Health Check provided by general medical practices: cross-sectional survey in high-risk patients. J Public Health (Bangkok). Oxford University Press; 2015;37: 210–217. doi: 10.1093/pubmed/fdu054 25118218
21. Baker C, Loughren EA, Crone D, Kallfa’ N. Patients’ perceptions of a NHS Health Check in the primary care setting. Qual Prim Care. 2014;22: 232–7. Available: http://www.ncbi.nlm.nih.gov/pubmed/25897543 25897543
22. University College of London. Health Survey for England [Internet]. [cited 16 Jan 2017]. Available: https://www.ucl.ac.uk/hssrg/studies/hse
23. University College of London. English Longitudinal Study of Aging [Internet]. [cited 16 Jan 2017]. Available: https://www.elsa-project.ac.uk/
24. Barendregt J, van Oortmarssen G, Vos T, Murray C. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr. 2003;1: 4. doi: 10.1186/1478-7954-1-4 12773212
25. Office for National Statistics. Deaths registered in England and Wales, 2011 [Internet]. Newport, Wales; 2013. Available: http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-27772730
26. Office for National Statistics. Cancer Registrations in England, 2011 [Internet]. Newport, Wales; 2013. Available: http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-302299
27. Office for National Statistics. Mortality Statistics: Deaths registered in England and Wales, 2012. London; 2014.
28. Health & Social Care Information Centre. National Diabetes Audit 2011–12 Report 2: Complications & Mortality [Internet]. Leeds; 2013. Available: https://digital.nhs.uk/catalogue/PUB12738
29. Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II—PIIS0140673613615706.pdf. In: The Lancet [Internet]. 2013 [cited 5 Dec 2013] pp. 1405–1412. Available: http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673613615706.pdf?id=410a13c7e856fa01:-537181ea:142b8fe4bec:1b371386088006979
30. Rait G, Walters K, Bottomley C, Petersen I, Iliffe S, Nazareth I. Survival of people with clinical diagnosis of dementia in primary care: cohort study. BMJ. 2010;341: c3584. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2917003&tool=pmcentrez&rendertype=abstract doi: 10.1136/bmj.c3584 20688840
31. National Centre for Social Research. Health Survey for England, 2012 [computer file]. Colchester; 2013.
32. Luengo-Fernandez R, Gray AM, Rothwell PM, Oxford Vascular Study on behalf of the OV. A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke. Stroke. American Heart Association, Inc.; 2012;43: 3343–51. doi: 10.1161/STROKEAHA.112.667204 23160884
33. British Heart Foundation Centre On Population Approaches For Non-Communicable Disease Prevention. Cardiovascular Disease Statistics 2015. London; 2016.
34. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ. 2012;344: d8059. doi: 10.1136/bmj.d8059 22279113
35. Lee S, Shafe ACE, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999–2008: time-trend analysis from the General Practice Research Database. BMJ Open. British Medical Journal Publishing Group; 2011;1: e000269. doi: 10.1136/bmjopen-2011-000269 22021893
36. Parkin DM. 2. Tobacco-attributable cancer burden in the UK in 2010. Br J Cancer. Cancer Research UK; 2011;105 Suppl: S6–S13. doi: 10.1038/bjc.2011.475 22158323
37. Lee Y, Back JH, Kim J, Kim S-H, Na DL, Cheong H-K, et al. Systematic review of health behavioral risks and cognitive health in older adults. Int Psychogeriatr. 2010;22: 174–87. doi: 10.1017/S1041610209991189 19883522
38. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study. Gandy S, editor. PLoS Med. Public Library of Science; 2009;6: e1000180. doi: 10.1371/journal.pmed.1000180 19901977
39. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10: 819–828. doi: 10.1016/S1474-4422(11)70072-2 21775213
40. Public Health England, UK Health Forum. Blackfriars Consensus on promoting brain health: Reducing risks for dementia in the population [Internet]. London; 2014. Available: https://www.alz.co.uk/sites/default/files/pdfs/Blackfriars-Consensus-Statement-promoting-brain-health.pdf
41. Schrijvers EMC, Verhaaren BFJ, Koudstaal PJ, Hofman A, Ikram MA, Breteler MMB. Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology. 2012;78: 1456–63. doi: 10.1212/WNL.0b013e3182553be6 22551732
42. Office for National Statistics. National Life Tables, 2010–2012. In: England, Interim Life Tables, 1980–82 to 2010–12 [Internet]. 2013. Available: http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-325699
43. Public Health England. NHS Health Check data. In: NHS Health Check data 2015 [Internet]. 2015 [cited 16 Jun 2015]. Available: http://www.healthcheck.nhs.uk/commissioners_and_providers/data/
44. Public Health England. NHS Health Check Best Practice Guidance. London; 2017.
45. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336: 1475–82. doi: 10.1136/bmj.39609.449676.25 18573856
46. Smolina K, Wright FL, Rayner M, Goldacre MJ. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ Cardiovasc Qual Outcomes. 2012;5: 532–40. doi: 10.1161/CIRCOUTCOMES.111.964700 22740013
47. Lee S, Shafe ACE, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999–2008: time-trend analysis from the General Practice Research Database. BMJ Open. British Medical Journal Publishing Group; 2011;1: e000269. doi: 10.1136/bmjopen-2011-000269 22021893
48. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5: 735–741. doi: 10.1016/S1474-4422(06)70537-3 16914401
49. NHS England. NHS Health Checks: National Data [Internet]. [cited 16 Mar 2015]. Available: https://www.healthcheck.nhs.uk/commissioners_and_providers/data/
50. Robson J, Dostal I, Sheikh A, Eldridge S, Madurasinghe V, Griffiths C, et al. NHS Health Check programme—National Evaluation 2009–2013. London; 2014.
51. Ahern AL, Wheeler GM, Aveyard P, Boyland EJ, Halford JCG, Mander AP, et al. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. Lancet (London, England). Elsevier; 2017;389: 2214–2225. doi: 10.1016/S0140-6736(17)30647-5 28478041
52. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125: 882–7.e1. doi: 10.1016/j.amjmed.2011.12.013 22748400
53. Lemstra M, Alsabbagh MW. Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis. Patient Prefer Adherence. Dove Press; 2014;8: 211–8. doi: 10.2147/PPA.S55382 24611002
54. Faculty of Public Health. Response from the Faculty of Public Health: Technical Consultation on Economic Modelling of a Policy of Vascular Checks. [Internet]. London; 2008. Available: http://www.fph.org.uk/uploads/DH_vascular_checks_0808.pdf
55. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34: 2940–8. doi: 10.1093/eurheartj/eht295 23907142
56. Ferguson J, Bauld L, Chesterman J, Judge K. The English smoking treatment services: one-year outcomes. Addiction. 2005;100: 59–69. doi: 10.1111/j.1360-0443.2005.01028.x 15755262
57. Stubbs RJ, Pallister C, Whybrow S, Avery A, Lavin J. Weight Outcomes Audit for 34,271 Adults Referred to a Primary Care/Commercial Weight Management Partnership Scheme. Obes Facts. 2011;4: 1–1. doi: 10.1159/000327249 21577018
58. Cholesterol Treatment Trialists’ (CTT) Collaboration, Fulcher J, O’Connell R, Voysey M, Emberson J, Blackwell L, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet. 2015;385: 1397–1405. doi: 10.1016/S0140-6736(14)61368-4 25579834
59. Heran BS, Wong MM, Heran IK, Wright JM. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension. In: Heran BS, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2008. p. CD003823. doi: 10.1002/14651858.CD003823.pub2 18843651
60. Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29: 2669–2680. doi: 10.1093/eurheartj/ehn427 18852183
61. Centers for Disease Control and Prevention (CDC). Quitting smoking among adults—United States, 2001–2010. MMWR Morb Mortal Wkly Rep. 2011;60: 1513–9. Available: http://www.ncbi.nlm.nih.gov/pubmed/22071589 22071589
62. Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des. Bentham Science Publishers; 2012;18: 1519–30. doi: 10.2174/138161212799504803 22364136
63. Robson J, Dostal I, Madurasinghe V, Sheikh A, Hull S, Boomla K, et al. The NHS Health Check programme: implementation in east London 2009–2011. BMJ Open. British Medical Journal Publishing Group; 2015;5: e007578. doi: 10.1136/bmjopen-2015-007578 25869692
64. Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D Scores for the United Kingdom. Med Decis Mak. SAGE PublicationsSage CA: Los Angeles, CA; 2011;31: 800–804. doi: 10.1177/0272989X11401031 21422468
65. Sutton S, Bickler G, Sancho-Aldridge J, Saidi G. Prospective study of predictors of attendance for breast screening in inner London. J Epidemiol Community Health. 1994;48: 65–73. Available: http://www.ncbi.nlm.nih.gov/pubmed/8138773 8138773
66. Waller J, Jackowska M, Marlow L, Wardle J. Exploring age differences in reasons for nonattendance for cervical screening: a qualitative study. BJOG An Int J Obstet Gynaecol. 2012;119: 26–32. doi: 10.1111/j.1471-0528.2011.03030.x 21668764
67. Johns LE, Moss SM, Trial Management Group. Randomized controlled trial of mammographic screening from age 40 (‘Age’ trial): patterns of screening attendance. J Med Screen. 2010;17: 37–43. doi: 10.1258/jms.2010.009091 20356944
68. Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK. Heart. BMJ Publishing Group Ltd and British Cardiovascular Society; 2016;102: 1945–1952. doi: 10.1136/heartjnl-2016-309573 27550425
69. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M, Chisholm D. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet (London, England). Springer, New York; 2011;378: 815–25. doi: 10.1016/S0140-6736(11)60814-3
70. Grey C, Jackson R, Wells S, Marshall R, Riddell T, Kerr AJ. Twenty-eight day and one-year case fatality after hospitalisation with an acute coronary syndrome: a nationwide data linkage study. Aust N Z J Public Health. 2014;38: 216–220. doi: 10.1111/1753-6405.12241 24890478
71. Davies CA, Leyland AH. Trends and inequalities in short-term acute myocardial infarction case fatality in Scotland, 1988–2004. Popul Health Metr. 2010;8: 33. doi: 10.1186/1478-7954-8-33 21134255
72. Office for National Statistics. Migration by Age. In: Census 2011 [Internet]. 2011 [cited 20 Nov 2017]. Available: https://www.nomisweb.co.uk/census/2011/UKMIG001/view/2092957699?rows=c_migr&cols=c_age
73. Crossan C, Lord J, Ryan R, Nherera L, Marshall T. Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study. Br J Gen Pract. 2017;67: e67–e77. doi: 10.3399/bjgp16X687973 27821671
74. Goldacre B, Smeeth L. Mass treatment with statins. BMJ. British Medical Journal Publishing Group; 2014;349: g4745. doi: 10.1136/bmj.g4745 25056140
75. Blakely T, Cobiac LJ, Cleghorn CL, Pearson AL, van der Deen FS, Kvizhinadze G, et al. Health, Health Inequality, and Cost Impacts of Annual Increases in Tobacco Tax: Multistate Life Table Modeling in New Zealand. PLoS Med. Public Library of Science; 2015;12: e1001856. doi: 10.1371/journal.pmed.1001856 26218517
76. Saxon DR, Eckel RH. Statin Intolerance: A Literature Review and Management Strategies. Prog Cardiovasc Dis. 2016;59: 153–164. doi: 10.1016/j.pcad.2016.07.009 27497504
77. Rose G. Sick individuals and sick populations. Int J Epidemiol. Oxford University Press; 2001;30: 427–432. doi: 10.1093/ije/30.3.427 11416056
78. He FJ, Brinsden HC, MacGregor GA. Salt reduction in the United Kingdom: a successful experiment in public health. J Hum Hypertens. 2014;28: 345–52. doi: 10.1038/jhh.2013.105 24172290
79. Department of Health. National Service Framework For Coronary Heart Disease [Internet]. London; 2000. Available: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/198931/National_Service_Framework_for_Coronary_Heart_Disease.pdf
80. Vascular Team Department of Health. Economic Modelling for Vascular Checks. London; 2008.
81. Fenton KA, Kelly M, Newton J, Patrick Z, Richards M. NHS Health Check: our approach to the evidence. 2013.
82. Eddy DM, Schlessinger L. Validation of the archimedes diabetes model. Diabetes Care. 2003;26: 3102–10. Available: http://www.ncbi.nlm.nih.gov/pubmed/14578246 14578246
83. Chang KC-M, Lee JT, Vamos EP, Soljak M, Johnston D, Khunti K, et al. Impact of the National Health Service Health Check on cardiovascular disease risk: a difference-in-differences matching analysis. CMAJ. Canadian Medical Association; 2016;188: E228–38. doi: 10.1503/cmaj.151201 27141033
84. Mytton O, Gray A, Rayner M, Rutter H. Could targeted food taxes improve health? J Epidemiol Community Heal. 2007/07/17. 2007;61: 689–694. doi: 10.1136/jech.2006.047746 17630367
85. Pharoah PDP, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N. Cost effectiveness of the NHS breast screening programme: life table model. BMJ. 2013;346: f2618. doi: 10.1136/bmj.f2618 23661112
86. Tappenden P, Chilcott J, Eggington S, Sakai H, Karnon J, Patnick J. Option appraisal of population-based colorectal cancer screening programmes in England. Gut. 2007;56: 677–684. doi: 10.1136/gut.2006.095109 17142648
87. National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification (CG181). London; 2016.
88. Godtfredsen NS, Prescott E. Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities. Clin Respir J. 2011;5: 187–194. doi: 10.1111/j.1752-699X.2011.00262.x 21689381
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2018 Číslo 3
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- Forced anal examinations to ascertain sexual orientation and sexual behavior: An abusive and medically unsound practice
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study
- Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care